People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $138.5M | $347.9M | 2018 |
| Sorriso Pharmaceuticals, Inc. | — | Biotechnology | Series B | $21.3M | $448.9M | 2021 |
| Curzion Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.5M | $133.1M | 2019 |
Susan Dube at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Susan Dube on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ed Mathers | 2 | 11 |
| Michael Grey | 2 | 10 |
| Edward Mathers | 1 | 12 |
| Patrick Heron | 1 | 11 |
| Jonathan Leff | 1 | 11 |
| Tiba Aynechi | 1 | 9 |
| Patrick J. Heron | 1 | 7 |
| Niall O'Donnell | 1 | 7 |
| Mark Chin | 1 | 4 |
| Johan Kordel | 1 | 4 |
| Laura Brege | 1 | 3 |
| Edward T. Mathers | 1 | 3 |
| William C. Fairey | 1 | 2 |
| Peter Radovich | 1 | 2 |
| Michael G. Grey | 1 | 2 |
| Eric Bjerkholt | 1 | 1 |
| Christopher Peetz | 1 | 1 |
| Timothy Walbert | 1 | 1 |
| Patrick C. Heron | 1 | 1 |
| Pamela Jonathan Vig | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.